Loading...

Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review

Nivolumab is a checkpoint inhibiting immunotherapeutic agent prescribed for the treatment of resistant cancers. Many immune-related adverse effects including neurological effects have been described, but central nervous system (CNS) toxicities are rarely reported. We present a 59-year-old Caucasian...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Med Res
Main Authors: Zafar, Zubair, Vogler, Carrie, Hudali, Tamer, Bhattarai, Mukul
Format: Artigo
Sprog:Inglês
Udgivet: Marshfield Clinic 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6546281/
https://ncbi.nlm.nih.gov/pubmed/31160476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2019.1417
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!